DRAFT
AGENDA: NCRI GENETIC VARIATION & CANCER WORKSHOP
Friday 3 February 2006
Royal Society, 6-9 Carlton Terrace London, SW1V 5AG
INTRODUCTION
Genetic Variation studies are providing new information about cancer at a massive
rate. While there is outstanding potential for application in cancer prevention
and care it is becoming clear that interpretation of data is a complex problem,
which needs to be approached in a systematic way if valid conclusions are to
be drawn. Genetic Variation data are a key part of the information available
to the cancer researcher and clinician. The requirements for reporting, storage,
acquisition and integration of these data across technologies such as genotyping,
diagnostics, array based technologies and emerging technologies in cancer research
and healthcare environment will be explored at this one day invitation only
workshop organised by the NCRI Informatics Initiative (www.cancerinformatics.org.uk).
The NCRI Board is committed to this initiative and future funding will be available
for relevant projects in this area.
DRAFT AGENDA
| TIME | SESSION | SPEAKER |
| 09.30 - 10.00 | COFFEE | |
| 10.00 - 10.10 | Introduction and Welcome | Richard Begent (NCRI Informatics Initiative) |
| 10.10 - 10.30 | Introduction
to the Workshop and overview of the current situation in Genetic Variation
and Cancer ‘The COSMIC database and website’ |
Richard Wooster (Wellcome Trust Sanger Institute) |
| 10.30 - 10.50 | UK Biobank - Implementation and Roll Out | Steve Walker (UK Biobank) |
| 10.50 - 11.10 | The Mutation
Viewer Pipeline: An End-to-End Solution for Storage, Analysis, and Visualization of Mutation Profiling Data |
Rakesh Nagarajan (Washington University in St. Louis) |
| 11.10 - 11.30 | Dealing with Genetic Variation Data: a diagnostic perspective | Chris Mattocks (Wessex Regional Genetics Service) |
| 11.30 - 11.50 | Genotype-Phenotype Databases: Challenges and Solutions | Anthony Brookes (University of Leicester) |
| 11.50 - 12.10 | Developing
Standards for Genetic Variation Datasets from Emerging Technologies |
Tina Boussard (PharmGKB) |
12.10 - 12.30 |
Genetic Variation and Cancer - an industry perspective | Tim French (Astra Zeneca) |
| 12.30 - 13.30 | LUNCH | |
| 13.30 - 14.00 | Introduction to the questions for the working groups | |
| 14.00 - 15.45 | WORKING GROUPS | |
| 15.45 - 16.15 | COFFEE | |
| 16.15 - 17.30 | Working Groups report back | |
17.30 - 18.00 |
Discussion | All |
18.00 - 19.00 |
WINE RECEPTION |